Vasoplegic Shock Treated with Methylene Blue Complicated by Severe Serotonin Syndrome (2017)

Peer-Reviewed Study · Chan BS, Becker T, Chiew AL, Abdalla AM, Robertson TA, Liu X, Roberts MS, Buckley NA · November 13, 2017

Chan BS et al., 2017-11-13: Case report of a 15-year-old who received methylene blue for refractory vasoplegic shock after a mixed overdose including venlafaxine, desvenlafaxine and fluoxetine, and developed severe serotonin syndrome lasting five days.

Twelve hours post ingestion, he developed severe Serotonin Syndrome that lasted 5 days as a result of interaction between MB, a reversible monoamine oxidase inhibitor (MAO-I), and the antidepressants taken in overdose.

Chan BS et al., 2017-11-13: Case report of a 15-year-old who received methylene blue for refractory vasoplegic shock after a mixed overdose including venlafaxine, desvenlafaxine and fluoxetine, and developed severe serotonin syndrome lasting five days. C1 case and C5 (dose/kinetics). Dose/route: intravenous methylene blue during resuscitation; the abstract does not give the mg/kg – the paper reports a calculated methylene blue half-life of 38 hours in this patient. Funder/conflicts: not stated in abstract (full text on PMC). Comparator: none. Study type: case report.